Drug
Cimicifuga racemosa
Cimicifuga racemosa is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
1
25%
Ph phase_2
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_4
Breast Cancer, Sexuality and Black Cohosh
NCT02467686
unknownphase_3
Black Cohosh Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women
NCT01487694
completedphase_2
Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms
NCT00066144
completedphase_1
Single-Dose Study of Black Cohosh and Red Clover
NCT00010959
Clinical Trials (4)
Showing 4 of 4 trials
NCT02467686Phase 4
Breast Cancer, Sexuality and Black Cohosh
NCT01487694Phase 3
Black Cohosh Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women
NCT00066144Phase 2
Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms
NCT00010959Phase 1
Single-Dose Study of Black Cohosh and Red Clover
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4